Recruiting
Phase 2

Descartes-08 for Patients With Systemic Lupus Erythematosus

Sponsor:

Cartesian Therapeutics

Code:

NCT06038474

Conditions

Systemic Lupus Erythematosus (SLE)

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Descartes-08

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-30. This information was provided to ClinicalTrials.gov by Cartesian Therapeutics on 2024-02-28.